Since decades, natural product-based antibiotics are the number one choice for the treatment of patients infected by bacteria. However, rising bacterial resistance limits the clinical application of these promising drugs worldwide. To reinstall their clinical use, AGILeBiotics employs its smart and patented synthetic method OxaSelect that converts existing antibiotics, which lost their efficacy, to novel […]
